Synthetic Bax-Anti Bcl(2) combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer

BACKGROUND: The synthetic biology technology which enhances the specificity and efficacy of treatment is a novel try in biomedical therapy during recent years. A high frequency of somatic mutations was shown in the human telomerase reverse transcriptase (hTERT) promoter in bladder cancer, indicating...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Exp Clin Cancer Res
Prif Awduron: Liu, Li, Liu, Yuchen, Zhang, Tianbiao, Wu, Hanwei, Lin, Muqi, Wang, Chaoliang, Zhan, Yonghao, Zhou, Qing, Qiao, Baoping, Sun, Xiaojuan, Zhang, Qiaoxia, Guo, Xiaoqiang, Zhao, Guoping, Zhang, Weixing, Huang, Weiren
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2016
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4705585/
https://ncbi.nlm.nih.gov/pubmed/26743236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0279-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg